...
首页> 外文期刊>Australasian Journal of Dermatology >A case of multicentric reticulohistiocytosis responsive to azathioprine in a patient with no underlying malignancy
【24h】

A case of multicentric reticulohistiocytosis responsive to azathioprine in a patient with no underlying malignancy

机译:无基础恶性肿瘤患者对硫唑嘌呤有反应的多中心网状组织细胞增多症一例

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Multicentric reticulohistiocytosis (MRH), a rare histiocytic systemic condition characterized by mutilating arthritis and multiple cutaneous nodules, has been associated with malignancy including that of the breast, thyroid and colon. An unsubstantiated link with infectious agents such as mycobacterium tuberculosis has been described. Many treatments have been used with varying success. We describe the case of a 60-year-old man with MRH and no underlying malignancy who initially responded well to azathioprine and whose disease recurred upon cessation. A second course of azathioprine administered in conjunction with antituberculous treatment resulted in disease control. Broader associations and features of this rare disease are discussed.
机译:多中心网状组织细胞增生症(MRH)是一种罕见的组织细胞性全身性疾病,其特征是破坏性关节炎和多个皮肤结节,与恶性肿瘤有关,包括乳腺癌,甲状腺癌和结肠癌。已经描述了与诸如结核分枝杆菌的传染因子的未经证实的联系。已经使用了许多治疗方法,并取得了不同的成功。我们描述了一个60岁的男性,患有MRH且没有潜在的恶性肿瘤,最初对硫唑嘌呤反应良好,并且戒烟后疾病复发,该病例为例。硫唑嘌呤的第二个疗程与抗结核治疗一起给药可控制疾病。讨论了这种罕见疾病的广泛关联和特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号